IN A009
Alternative Names: IN-A009Latest Information Update: 28 May 2024
At a glance
- Originator HK inno.N
- Class Antineoplastics; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Non-alcoholic steatohepatitis
Highest Development Phases
- Research Cancer
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 28 May 2024 No recent reports of development identified for research development in Non-alcoholic-steatohepatitis in South Korea
- 01 Mar 2021 Early research in Cancer in South Korea before March 2021 (HK inno.N pipeline, March 2021)
- 29 Jul 2020 IN A009 is available for licensing as of 29 Jul 2020. http://www.inno-n.com/